Literature DB >> 16432991

Feasibility of endoscopic ultrasound-guided portal vein embolization with Enteryx.

K Matthes1, D Sahani, N S Holalkere, M Mino-Kenudson, W R Brugge.   

Abstract

BACKGROUND: Portal vein embolization (PVE) has been used as a preoperative strategy to induce hepatic lobar atrophy and contralateral lobe hypertrophy. We determined the feasibility of endoscopic ultrasound (EUS)-guided Enteryx (EVAL/ethylene-vinyl alcohol copolymer) embolization of the portal vein (EUS-PVE) in an animal model as a potential, minimally invasive, endoscopic technique.
METHODS: EUS-guided embolization of the portal vein (EUS-PVE) using Enteryx was performed in a Yorkshire breed swine. Portal pressure measurements were obtained before and after vascular embolization. The animal was carefully monitored for seven days for evidence of abdominal pain, shock, or bleeding. An upper abdominal contrast-CT scan was performed to verify the location of the embolus.
RESULTS: The PV pressure increased from 3 mmHg at baseline to a mean of 15 mmHg after EUS-PVE. The CT-scan on day 4 demonstrated Enteryx in the main portal vein with extension into the left branch. At sacrifice on day 7, a solid thrombus was visible grossly and histologically inside the main portal vein and the left branch of the portal vein.
CONCLUSIONS: Selective embolization of the portal vein by EUS guidance appears to be feasible and a potential, minimally invasive, preoperative treatment option for patients undergoing extensive hepatectomy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16432991

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


  10 in total

1.  Endoscopic ultrasound guided vascular access and therapy: A promising indication.

Authors:  Enrique Vazquez-Sequeiros; Jose Ramon Foruny Olcina
Journal:  World J Gastrointest Endosc       Date:  2010-06-16

Review 2.  Hepatic applications of endoscopic ultrasound: Current status and future directions.

Authors:  Indu Srinivasan; Shou-Jiang Tang; Andreas S Vilmann; John Menachery; Peter Vilmann
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

Review 3.  Endoscopic ultrasound-guided interventions in special situations.

Authors:  Varayu Prachayakul; Pitulak Aswakul
Journal:  World J Gastrointest Endosc       Date:  2016-01-25

4.  Interventional endoscopic ultrasound: A new promising way for intrahepatic portosystemic shunt with portal pressure gradient.

Authors:  Laurent Poincloux; Pascal Chabrot; Aurélien Mulliez; Julien Genes; Louis Boyer; Armando Abergel
Journal:  Endosc Ultrasound       Date:  2017 Nov-Dec       Impact factor: 5.628

5.  EUS-guided vascular interventions.

Authors:  Idan Levy; Kenneth F Binmoeller
Journal:  Endosc Ultrasound       Date:  2018 Jul-Aug       Impact factor: 5.628

Review 6.  The role of EUS in diagnosis and treatment of liver disorders.

Authors:  Sara Campos; Jan-Werner Poley; Lydi van Driel; Marco J Bruno
Journal:  Endosc Int Open       Date:  2019-10-01

Review 7.  Role of endoscopic ultrasound in anticancer therapy: Current evidence and future perspectives.

Authors:  Andre Bratanic; Dorotea Bozic; Antonio Mestrovic; Dinko Martinovic; Marko Kumric; Tina Ticinovic Kurir; Josko Bozic
Journal:  World J Gastrointest Oncol       Date:  2021-12-15

8.  Role of endoscopic ultrasound in the field of hepatology: Recent advances and future trends.

Authors:  Jahnvi Dhar; Jayanta Samanta
Journal:  World J Hepatol       Date:  2021-11-27

9.  EUS-Guided Vascular Procedures: A Literature Review.

Authors:  Tomislav Bokun; Ivica Grgurevic; Milan Kujundzic; Marko Banic
Journal:  Gastroenterol Res Pract       Date:  2013-05-07       Impact factor: 2.260

10.  Feasibility and safety of EUS-guided selective portal vein embolization with a coil and cyanoacrylate in a live porcine model.

Authors:  Tae Young Park; Dong-Wan Seo; Hyeon-Ji Kang; Tae Jun Song; Do Hyun Park; Sang Soo Lee; Sung Koo Lee; Myung-Hwan Kim
Journal:  Endosc Ultrasound       Date:  2018 Nov-Dec       Impact factor: 5.628

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.